Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin timing before uterine incision during elective caesarean section
PACTR202111830813291Completed
- Sponsor
- Nwigboji Ndukwe Wilson
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Nwigboji Ndukwe Wilson. Primary endpoint: Mean blood loss during elective caesarean section. Started Sep 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202111830813291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202111830813291.